Showing results (381-390 of 532) with videos related to
Sort By:
Pageof 54
Journal of the American Medical Informatics Association : JAMIA|August 10, 2024
PheMIME: an interactive web app and knowledge base for phenome-wide, multi-institutional multimorbidity analysisSiwei Zhang, Nick Strayer, Tess Vessels, et al.BMJ (Clinical Research Ed.)|January 9, 2025
Effectiveness of shared decision making strategies for stroke prevention among patients with atrial fibrillation: cluster randomized controlled trialElissa M Ozanne, Geoffrey D Barnes, Juan P Brito, et al.Medrxiv : the Preprint Server for Health Sciences|January 10, 2024
Multi-site validation of a functional assay to adjudicate SCN5A Brugada Syndrome-associated variantsJoanne G Ma, Matthew J O'Neill, Ebony Richardson, et al.Plos One|February 7, 2019
Association of genetic variants previously implicated in coronary artery disease with age at onset of coronary artery disease requiring revascularizationsCharlotte Andersson, Maria Lukács Krogager, Regitze Kuhr Skals, et al.JAMA Cardiology|May 12, 2017
Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical TrialPrince J Kannankeril, Jeremy P Moore, Marina Cerrone, et al.Human Genetics|September 13, 2013
A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effectsKhader Shameer, Joshua C Denny, Keyue Ding, et al.Journal of the American Heart Association|October 18, 2024
Promise and Peril of a Genotype-First Approach to Mendelian Cardiovascular DiseaseBabken Asatryan, Brittney Murray, Rafik Tadros, et al.European Heart Journal|July 19, 2024
Genetic testing in early-onset atrial fibrillationShinwan Kany, Sean J Jurgens, Joel T Rämö, et al.Circulation. Genomic and Precision Medicine|July 2, 2024
Multisite Validation of a Functional Assay to Adjudicate SCN5A Brugada Syndrome-Associated VariantsJoanne G Ma, Matthew J O'Neill, Ebony Richardson, et al.Journal of Neurosurgery|November 21, 2015
CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic diseaseBrian L Hoh, Yan Gong, Caitrin W McDonough, et al.Pageof 54